Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

EMCURE PHARMACEUTICALS LTD.

NSE : EMCUREBSE : 544210ISIN CODE : INE168P01015Industry : Pharmaceuticals & DrugsHouse : Private

BSE1425.450.05 (+0 %)

PREV CLOSE ( ) 1425.40

OPEN PRICE ( ) 1425.40

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 16990

TODAY'S LOW / HIGH ( )1403.05 1455.00

52 WK LOW / HIGH ( )890 1577.5

NSE1425.20-0.5 (-0.04 %)

PREV CLOSE( ) 1425.70

OPEN PRICE ( ) 1425.70

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 1425.20 (893)

VOLUME 215470

TODAY'S LOW / HIGH( ) 1402.60 1458.00

52 WK LOW / HIGH ( )889 1580

Select year

(Rs.in Million)

Particulars

Mar 2024

Mar 2023

Mar 2022

Mar 2021

Mar 2020

Profit Before Tax

7272.28

7472.15

9725.48

6573.27

1053.35

Adjustment

5431.47

4923.49

3987.42

5820.95

6110.99

Changes In working Capital

505.17

-2922.35

-2919.06

-3345.54

-1239.81

Cash Flow after changes in Working Capital

13208.92

9473.29

10793.84

9048.68

5924.53

Cash Flow from Operating Activities

10972.40

7468.53

7682.07

7044.35

5003.02

Cash Flow from Investing Activities

-7125.12

-4676.85

-7887.91

-2518.48

-1637.60

Cash Flow from Financing Activities

-1642.06

-1453.97

-1518.51

-1889.04

-3005.12

Net Cash Inflow / Outflow

2205.22

1337.71

-1724.35

2636.83

360.30

Opening Cash & Cash Equivalents

-1745.29

-3081.72

-3500.42

-6091.08

-6409.64

Cash & Cash Equivalent on Amalgamation / Take over / Merger

2141.19

Cash & Cash Equivalent of Subsidiaries under liquidations

Translation adjustment on reserves / op cash balalces frgn subsidiaries

Effect of Foreign Exchange Fluctuations

-20.02

-1.28

1.86

-46.17

-41.74

Closing Cash & Cash Equivalent

439.91

-1745.29

-3081.72

-3500.42

-6091.08